CANCERFAX SERVICES OVERVIEW: FROM
MEDICAL RECORDS TO DISCHARGE

Cancer treatment decisions are not just medical. They are also logistical, financial, and emotional. A family may be balancing several pressures at once: confirming the diagnosis, understanding what the next treatment really involves, organising finances, deciding whether to travel, and protecting an unwell patient from further stress. In that situation, fragmented advice from different hospitals, unverified medical tourism agents, or incomplete online research can lead to decisions that are expensive, slow, or medically unsuitable. CancerFax exists to bring all of that into one structured pathway. The clinical questions are answered by qualified oncology teams. The logistics are handled by experienced coordinators. The communication is honest, even when the answer is difficult. And the entire process stays focused on one outcome: helping the family take the next responsible step for the patient.

Our work is organised into eight connected stages. Most families pass through every stage. Some, depending on their case, may stop after stage two or three because a clear answer has already been reached. The stages are not rigid steps; they are a framework that adapts to each patient. Stage 1. First contact and report submission The journey starts when a family reaches out by email, WhatsApp, or the website form. At first contact, we ask a few focused questions to understand the diagnosis, the patient's current condition, what has already been done, and what the family is hoping to achieve. We then explain how to share medical records securely. Patients can submit reports as scanned PDFs, photos of physical reports, or digital files. There is no charge for this initial contact and no obligation to proceed further. Stage 2. Medical record review and case organisation Reports often arrive in a mixed state: pages out of order, key investigations missing, language differences, or duplicate copies. Before any case can be sent for medical review, the records have to be organised into a clean, structured file. Our team builds a case summary that includes diagnosis, stage, pathology and immunohistochemistry findings, molecular or NGS results where available, imaging summary, full treatment history with dates and cycles, current medicines, and the most recent clinical status. We also flag missing investigations that the case will need before a meaningful review is possible, such as PET CT, MRI, IHC for specific markers, or NGS panels. Stage 3. Clinical suitability assessment Once the records are organised, the case is reviewed internally to identify what kind of treatment pathway is realistic. This is where many medical tourism platforms stop, but it is where CancerFax does some of its most important work. Different patients need different things. A newly diagnosed patient may simply need a strong second opinion to confirm whether the proposed local plan is appropriate. A relapsed patient may need to be matched to specific advanced therapy or clinical trial options. A patient in a fragile clinical state may need to be told honestly that international travel is not safe right now and that local stabilisation should come first. This stage protects families from spending time, money, and energy on directions that are not appropriate for the patient's actual situation. Stage 4. Second opinion and hospital matching Once a realistic pathway has been identified, the case is matched with the most relevant hospital, department, or clinical trial team. This is not a generic referral. We consider diagnosis, stage, prior treatment, biomarker profile, urgency, expected stay duration, and the patient's ability to travel. The case is shared with appropriate oncology teams, typically in China or India, and the family receives a structured second opinion that includes diagnostic agreement or clarification, comments on prior treatment, suggested treatment pathway, and an early indication of feasibility. If more than one hospital is suitable, we explain the differences clearly so the family can choose. Stage 5. Treatment planning and cost clarity Once a hospital or trial team accepts the case for management, the family receives a planning package: an overview of the proposed treatment, the likely sequence of admission and procedures, expected stay duration, an estimated cost range, and the documents that will need to be carried. We are careful with cost language. Cancer treatment costs depend heavily on the patient's condition at the time of admission, the need for ICU or supportive care, blood products, infection management, and complications. We give realistic ranges and explain what is included and what may be added later, so families are not surprised at the hospital. Stage 6. Visa, travel, and admission coordination Once the family is ready to proceed, the practical work begins. We coordinate the medical visa invitation letter, advise on flight and travel timing, suggest accommodation that is suitable for cancer patients (close to the hospital, with access to a kitchen where needed), and align everything with the hospital's admission window. We also arrange interpreter support and brief the family on what to expect on day one: which department to report to, what documents to carry in original, what investigations may be repeated locally, and what initial costs to be ready for. Stage 7. On-ground hospital support during treatment From admission through discharge, CancerFax stays involved. The family has a single point of contact who can communicate with the hospital, coordinate with the treating doctors, and translate medical updates into plain language for relatives back home. If the treatment plan changes during admission, which is common in oncology, we help the family understand why, what the alternatives are, and what questions to ask. For longer admissions involving surgery, transplant, cell therapy, radiation, or trial-based treatment, this continuity is one of the most important things we provide. The patient and family are not navigating a foreign healthcare system alone. Stage 8. Discharge and home-country follow-up Discharge is not the end of the journey. Cancer treatment usually requires structured follow-up: scans at fixed intervals, blood work, medicines that must be continued, and watch-outs for complications or recurrence. Before the family leaves the hospital, we help collect the discharge summary, treatment records, prescriptions, and follow-up schedule in a clean format that the patient's local oncologist can use. We also stay available for follow-up questions, scan reviews, and re-engagement if the disease behaviour changes later. Many families return to us months or years later not because something has gone wrong, but because they want their original navigator to look at the next set of reports.

The table below summarises the eight stages and what families typically receive at each step.

The strength of every stage that follows depends on the quality of records shared at the start. We typically ask for: If reports are in a regional language, English translations help the review move faster. Where reports are missing, our team helps the family identify what to request from the treating hospital before submission.

• Latest medical summary and diagnosis report

  Latest medical summary and diagnosis report

• Pathology and immunohistochemistry reports

  Pathology and immunohistochemistry reports

• NGS or molecular testing reports, if available

  NGS or molecular testing reports, if available

• PET CT, CT, MRI, ultrasound, and other imaging reports

  PET CT, CT, MRI, ultrasound, and other imaging reports

• Recent blood work, including liver and kidney function

  Recent blood work, including liver and kidney function

• Tumour marker reports where relevant

  Tumour marker reports where relevant

• Detailed treatment history with chemotherapy regimens, doses

  Detailed treatment history with chemotherapy regimens, doses, dates, and cycles

• Surgery notes and discharge summaries, if applicable

  Surgery notes and discharge summaries, if applicable

• Radiation summaries, if applicable

  Radiation summaries, if applicable

• Immunotherapy and targeted therapy history

  Immunotherapy and targeted therapy history

• Current medicines and the treating doctor's most recent opin

  Current medicines and the treating doctor's most recent opinion

• Information on availability of biopsy blocks or unstained sl

  Information on availability of biopsy blocks or unstained slides for review

CancerFax is built for complex oncology cases rather than general medical tourism queries. Patients who typically benefit include: If a case is straightforward and well-managed locally, we will say so. Not every family needs international navigation, and recommending it when it is not needed would not be honest.

• Patients with relapsed or refractory cancers exploring CAR T

  Patients with relapsed or refractory cancers exploring CAR T-cell therapy, CAR NK therapy, TIL therapy, or other cell therapies

• Patients exploring tumour therapeutic vaccines, oncolytic vi

  Patients exploring tumour therapeutic vaccines, oncolytic virus therapy, or Gendicine-type gene therapy options

• Patients with solid tumours considering proton therapy, BNCT

  Patients with solid tumours considering proton therapy, BNCT, HIFU, TACE, TARE, or HIPEC

• Patients whose molecular testing has shown actionable findin

  Patients whose molecular testing has shown actionable findings and who want a precision oncology review

• Patients looking at clinical trials in China, India, or othe

  Patients looking at clinical trials in China, India, or other international centres

• Patients comparing treatment options across countries before

  Patients comparing treatment options across countries before making a major decision

• Families who want a single point of coordination rather than

  Families who want a single point of coordination rather than juggling multiple agents and hospitals

CancerFax helps families across many regions, with a particular focus on patients from South Asia, Southeast Asia, the Middle East, North Africa, the CIS region, and parts of Eastern Europe. Treatment access is most often arranged in: The right country for a given patient depends on the diagnosis, the proposed treatment, urgency, language, visa, and family circumstances. We help families weigh these factors honestly rather than pushing any single corridor.

• China, for advanced cell therapies, gene therapy, oncolytic

  China, for advanced cell therapies, gene therapy, oncolytic virus therapy, proton and heavy ion therapy, and a wide range of clinical trials

• India, for cost-sensitive access to surgery, transplant, rad

  India, for cost-sensitive access to surgery, transplant, radiation, targeted therapy, and select advanced therapies

• Other international centres, including Singapore, Japan, and

  Other international centres, including Singapore, Japan, and Germany, for selected complex cases

Frequently Asked Questions

Answers to common questions from patients and families.

Structured reference data summarizing key information for this topic.